Skip to content
Catalyst

PapersPMID:18566298

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Arteriosclerosis, thrombosis, and vascular biology2008The record ↗

  1. Finding, very limited evidenceraisesHDL cholesterol

What moved

1 findingHow to read these marks →
  • Increases HDL cholesterol

    very limitedreplicated ×2

    “Niacin significantly increased HDL cholesterol and apoA-I concentrations, associated with a significant increase in apoA-I production rate (PR) and no change in fractional catabolic rate (FCR).”
    Study
    RCT
    Dose studied
    extended-release niacin 2 g/d
    Population
    Five men with combined hyperlipidemia; extended-release niacin alone, assessed in a kinetic study relative to placebo

Study record

Design
crossover trial / randomised controlled trial
Species
human
Population
men with combined hyperlipidemia
Participants
5
Comparator
placebo
Duration
not reported
Endpoints measured
14